Direkt zum Inhalt
Merck

Interaction of drug based binuclear mixed-ligand complexes with DNA.

Bioorganic & medicinal chemistry (2009-07-08)
Mohan N Patel, Mehulsinh R Chhasatia, Deepen S Gandhi
ZUSAMMENFASSUNG

Here in we tried to increase an antibacterial activity of ciprofloxacin drug due to formation of mixed-ligand complexes. Synthesized compounds were found to be more potent compare to drugs, ligands and metal salt against selective gram((+ve)) and gram((-ve)) organisms. Interaction of the complexes with nucleic acid (DNA) were investigated using spectroscopic technique, viscosity measurement and gel electrophoresis and it was found that the complexes bind to DNA via intercalative mode.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
o-Phenylendiamin, flaked, 99.5%
Sigma-Aldrich
Ethylendiamin, ReagentPlus®, ≥99%
Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
o-Phenylendiamin, Peroxidase substrate, ≥98.0%, powder
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Ethylendiamin, purified by redistillation, ≥99.5%
Sigma-Aldrich
1,8-Diaminonaphthalin, 99%
Sigma-Aldrich
o-Phenylendiamin, tablet, 20 mg substrate per tablet
Sigma-Aldrich
Ethylendiamin, BioXtra
Sigma-Aldrich
Ethylendiamin, puriss. p.a., absolute, ≥99.5% (GC)
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Supelco
Ethylendiamin, analytical standard
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Ethylendiamin -Lösung, technical, 75-80%
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Sparfloxacin, ≥98.0% (HPLC)
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Ethylendiamin, meets USP testing specifications
Supelco
Norfloxacin, VETRANAL®, analytical standard
Supelco
Ofloxacin, VETRANAL®, analytical standard